Kindred Biosciences, Inc.
(NASDAQ : KIN)

( )
KIN After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Yes, 3x ETFs are Awesome!
Like TNA, UGAZ, UWTI, NUGT? We do too...Join Up!
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Generic
symbolcompany%chnglast%shortavg$volume
AGNAllergan plc
1.10%164.212.9%$930.37m
ZTSZoetis, Inc. Class A
-0.73%113.031.9%$267.47m
TEVATeva Pharmaceutical Industries Limited Sponsored ADR
0.80%8.882.0%$200.86m
MYLMylan N.V.
0.05%18.663.2%$139.21m
JAGXJaguar Animal Health, Inc.
-2.42%4.849.8%$13.83m
TXMDTherapeuticsMD, Inc.
1.22%2.4924.9%$10.31m
RDYDr. Reddy's Laboratories Ltd. Sponsored ADR
1.60%36.852.0%$7.19m
TAROTaro Pharmaceutical Industries Ltd.
-0.69%84.576.4%$6.47m
ABEOAbeona Therapeutics, Inc.
-2.17%4.517.6%$3.14m
PETXAratana Therapeutics, Inc.
-1.34%5.168.5%$2.35m
LFVNLifeVantage Corporation
0.62%11.373.3%$0.96m
KINKindred Biosciences, Inc.
-3.39%8.260.3%$0.83m
CPHIChina Pharma Holdings, Inc.
-1.04%0.290.1%$0.10m

Company Profile

Kindred Biosciences, Inc. is a development-stage biopharmaceutical company, which focuses on saving and improving the lives of pets. The company was founded by Richard Chin and Denise M. Bevers on September 25, 2012 and is headquartered in Burlingame, CA.